Juventas Therapeutics, headquartered in Cleveland, OH, is a privately-held clinical-stage biotechnology company developing a pipeline of regenerative therapies to treat lifeâ€“threatening diseases. Founded in 2007 with an exclusive license from the Cleveland Clinic, Juventas has transitioned its therapeutic platform from concept to initiation of mid-stage clinical trials. Investors include Triathlon Medical Venture Partners, Early Stage Partners, Fletcher Spaght Ventures, Reservoir Venture Partners, North Coast Angel Fund, X Gen Ltd., JumpStart Inc., and Blue Chip Venture Co. The company has received nondilutive grant support through the Ohio Third Frontier funded Cleveland Clinic Ohio BioValidation Fund, Global Cardiovascular Innovation Center and Center for Stem Cell & Regenerative Medicine.
Current Team (4)Update
Funding Rounds (3) - $39.2MUpdate
Board Members and Advisors (4)Update
North Coast Angel Fund is a contributed capital and “sidecar” pre-seed investment fund investing...
Venture Investors is a premier provider of seed and early stage venture capital in the Midwest.
TVI's mission is to identify, help create and support the development of therapeutic...
Venture Capital Firm
NY VC in early/late stage in performance
venture capital firm
Investing in Biomedical Innovation
3615 Superior Avenue,
Cleveland, OH 44114